Search by Drug Name or NDC

NDC 15370-0170-60 RELAFEN DS 1000 mg/1 Details

RELAFEN DS 1000 mg/1

RELAFEN DS is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Carwin Pharmaceutical Associates, LLC. The primary component is NABUMETONE.

MedlinePlus Drug Summary

Nabumetone is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). Nabumetone is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Related Packages: 15370-0170-60
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nabumetone

Product Information

NDC	15370-0170
Product ID	15370-170_48aa3640-1dd2-4693-9b0d-a99595b97a0e
Associated GPIs	66100055000340
GCN Sequence Number	041308
GCN Sequence Number Description	nabumetone TABLET 1000 MG ORAL
HIC3	S2B
HIC3 Description	NSAIDS, CYCLOOXYGENASE INHIBITOR TYPE ANALGESICS
GCN	94457
HICL Sequence Number	006311
HICL Sequence Number Description	NABUMETONE
Brand/Generic	Brand
Proprietary Name	RELAFEN DS
Proprietary Name Suffix	n/a
Non-Proprietary Name	NABUMETONE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	1000
Active Ingredient Units	mg/1
Substance Name	NABUMETONE
Labeler Name	Carwin Pharmaceutical Associates, LLC
Pharmaceutical Class	Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA203166
Listing Certified Through	2025-12-31

Package

NDC 15370-0170-60 (15370017060)

Pricing Information	N/A
NDC Package Code	15370-170-60
Billing NDC	15370017060
Package	60 TABLET in 1 BOTTLE, PLASTIC (15370-170-60)
Marketing Start Date	2020-02-28
NDC Exclude Flag	N